Hyperfractionated-accelerated radiotherapy followed by radical surgery in locally advanced tumors of the oral cavity

Strahlentherapie und Onkologie

Volumn 182, Issue 3, 2006, Pages 157-163

  Hoeller, Ulrike ^a   Biertz, Iris ^b   Flinzberg, Sebastian ^b   Tribius, Silke ^b   Schmelzle, Reiner ^b   Alberti, Winfried ^b  

^a VIVANTES KLINIKUM NEUKÖLLN   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Head and neck cancer; Hyperfractionated radiotherapy; Late effects; Surgery

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CONTROL; CANCER PATIENT; CANCER REGRESSION; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CERVICAL LYMPH NODE; FEMALE; FISTULA; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MOUTH CANCER; NASOGASTRIC TUBE; NECK DISSECTION; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RETROSPECTIVE STUDY; RISK BENEFIT ANALYSIS; SALVAGE THERAPY; TREATMENT OUTCOME; TREATMENT PLANNING; WOUND HEALING IMPAIRMENT; CLINICAL TRIAL; METASTASIS; METHODOLOGY; MIDDLE AGED; MORTALITY; MOUTH TUMOR; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; RADIOTHERAPY; SURVIVAL;

ADULT; AGED; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM METASTASIS; NEOPLASM STAGING; RADIOTHERAPY; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 33646102693     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-006-1472-5     Document Type: Article

References (35)

1. Argiris A, Stenson KM, Brockstein BE, et al. Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer. Head Neck 2004;26:447-55.
2. Baumann M, Bentzen SM, Ang KK. Hyperfractionated radiotherapy in head and neck cancer: a second look at the clinical data. Radiother Oncol 1998;46:127-30.
3. Beck-Bornholdt HP, Dubben HH, Liertz-Petersen C, et al. Hyperfractionation: where do we stand? Radiother Oncol 1997;43:1-21.
4. Brizel DM, Albers ME, Fisher SR, et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 1998;338:1798-804.
5. Brizel DM, Prosnitz RG, Hunter S, et al. Necessity for aduvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2004;58:1418-23.
6. Budach V, Stuschke M, Budach W, et al. Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the Radiotherapy Cooperative Clinical Trials Group of the German Cancer Society 95-06 prospective randomized trial. J Clin Oncol 2005;23:1125-35.
7. Byhardt RW, Cox JD. Patterns of failure and results of preoperative irradiation vs radiation alone in carcinoma of the pyriform sinus. Int J Radiat Oncol Biol Phys 1980;6:1135-41.
8. Dubben HH, Thames HD, Beck-Bornholdt HP. Tumor volume: a basic and specific response predictor in radiotherapy. Radiother Oncol 1998;47:167-74.
9. Dunst J, Stadler P, Becker A, et al. Tumor volume and tumor hypoxia in head and neck cancers. The amount of the hypoxic volume is important. Strahlenther Onkol 2003;179:521-6.
10. Ernst-Stecken A, Grabenbauer G, Ira H, et al. Phase II trial of hyperfractionated accelerated split-course radiochemotherapy with 5-FU and Cis-DDP in advanced head and neck cancer. Results and toxicity. Strahlenther Onkol 2004;180:805-10.
11. Frank DK, Hu KS, Culliney BE, et al. Planned neck dissection after concomitant radiochemotherapy for advanced head and neck cancer. Laryngoscope 2005;115:1015-20.
12. Fu KK, Pajak FP, Trotti A, et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 2000;48:7-16.
13. Grabenbauer GG, Rodel C, Ernst-Stecken A, et al. Neck dissection following radiochemotherapy of advanced head and neck cancer - for selected cases only? Radiother Oncol 2003;66:57-63.
14. Hehr T, Classen J, Schreck U, et al. Selective lymph node dissection following hyperfractionated accelerated radio-(chemo-)therapy for advanced head and neck cancer. Strahlenther Onkol 2002;178:363-8.
15. Herrmann T, Baumann M. Prolongation of latency or overall treatment time by unplanned radiation pauses. The clinical importance of compensation. Strahlenther Onkol 2005;181:65-76.
16. Horiot JC, Le Fur R, Nguyen TD, et al. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC Cooperative Group of Radiotherapy. Radiother Oncol 1992;25:231-41.
17. Jeremic B, Shibamoto Y, Milicic B, et al. Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial. J Clin Oncol 2000;18:1458-64.
18. Johnson C, Silverman L, Clay L, et al. Radiotherapeutic management of bulky cervical lymphadenopathy of the head and neck: is post-radiotherapy neck dissection necessary? Radiat Oncol Investig 1998;6:52-7.
19. Johnson CR, Khandelwal SR, Schmidt-Ullrich RK, et al. The influence of quantitative tumor volume measurements on local control in advanced head and neck cancer using concomitant boost accelerated superfractionated irradiation. Int J Radiat Oncol Biol Phys 1995;32:635-41.
20. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
21. Kuhnt T, Jirsak N, Muller AC, et al. Quantitative and qualitative investigation of salivary gland function in dependence on irradiation dose and volume for reduction of xerostomia in patients with head and neck cancer. Strahlenther Onkol 2005;181:520-8.
22. Kurek R, Kalogera-Fountzila A, Muskalla K, et al. Usefulness of tumor volumetry as a prognostic factor of survival in head and neck cancer. Strahlenther Onkol 2003;179:292-7.
23. Lavertu P, Bonafede JP, Adelstein DJ, et al. Comparison of surgical complications after organ-preservation therapy in patients with stage III or IV squamous cell head and neck cancer. Arch Otolaryngol Head Neck Surg 1998;124:401-6.
24. Marcial VA, Gelber R, Kramer S, et al. Does preoperative irradiation increase the rate of surgical complications in carcinoma of the head and neck? Cancer 1982;49:1297-301.
25. Newman JP, Terris DJ, Pinto HA, et al. Surgical morbidity of neck dissection after chemoradiotherapy in advanced head and neck cancer. Ann Otol Rhinol Laryngol 1997;106:117-22.
26. Parsons JT, Mendenhall WM, Cassisi NJ, et al. Neck dissection after twice-a-day radiotherapy: morbidity and recurrence rates. Head Neck 1989;11:400-4.
27. Pignon JP, Bourhis J, Domenge C, et al. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 2000;355:949-55.
28. Rudat V, Dietz A, Schramm O, et al. Prognostic impact of total tumor volume and hemoglobin concentration on the outcome of patients with advanced head and neck cancer after concmitant boost radiochemotherapy. Radiother Oncol 1999;53:119-25.
29. Salz H, Wieczorek T, Scheithauer M, et al. IMRT with compensator for head-and-neck cancers. Treatment technique, dosimetric accuracy and practical experiences. Strahlenther Onkol 2005;181:665-72.
30. Sassler AM, Esclamado RM, Gregory TW. Surgery after organ preservation therapy. Arch Otolaryngol Head Neck Surg 1995;121:162-5.
31. Staar S, Rudat V, Stuetzer H, et al. Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy - results of a multicentric randomised German trial in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2001;50:1161-71.
32. Stuschke M, Thames HD. Hyperfractionated radiotherapy of human tumors: overview of the randomized clinical trials. Int J Radiat Oncol Biol Phys 1997;37:259-67.
33. Teknos TN, Myers LL. Surgical reconstruction after chemotherapy or radiation. Problems and solutions. Head Neck Cancer 1999;13:679-87.
34. Trotti A, Fu KK, Pajak TF, et al. Long-term outcomes of RTOG 90-03: a comparison of hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2005;63:Suppl 1:S70.
35. Tupchong L, Scott CB, Blitzer PH. Randomized study of preoperative versus postoperative radiation therapy in advanced head and neck carcinoma: long-term follow-up of RTOG study 73-03. Int J Radiat Oncol Biol Phys 1991;20:21-8.